Network Version
Bicyclol Data Sheet
| Product Name: | Bicyclol |
 |
|---|---|---|
| CAS No.: | 118159-48-1 | |
| Cat. No.: | HY-B0766 | |
| MWt: | 390.34 | |
| Formula: | C19H18O9 | |
| Purity : | >98% | |
| Solubility: | DMSO : ≥ 68 mg/mL (174.21 mM) | |
| Mechanisms: | Target: Cancer Infection | |
| Biological Activity: | ||
| Bicyclol(SY 801) is a anti-hepatitis drug. Target: HBV Oral administration of bicyclol normalized the elevated serum transaminases (ALT, AST) by approximately 50% in chronic viral hepatitis B and C, and also showed certain level of inhibiting HBV and HCV replication. No noticeable adverse reaction has been observed. In combination therapy of bicyclol with interferon alpha, lamivudine and adefovir dipivoxil in HBV or HCV, bicyclol may potentiate the anti-viral efficacy and reduce YMDD mutant and side effects. In 2004 China FDA issued license to manufacture bicyclol. Since then bicyclol has been widely used to treat chronic HBV and HCV in China [1]. | ||
1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA
Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected] Web:www.medchemexpress.com